2702 Introduction: To describe the diagnostic needs of patients with prostate cancer. To
illustrate the utility of positron emission tomography (PET) to address those needs. To …

Positron emission tomography (PET) imaging in prostate cancer has advanced significantly
in the past decade with prostate cancer targeted radiopharmaceuticals now playing a …

775 Learning Objectives: 1. Review the translational and clinical imaging literature on the
role of PET in prostate cancer. 2. List the major radiotracers used in the PET imaging …

Prostate cancer (PCa) is one of the few neoplasms that are not well served by 18F-
Fluorodeoxyglucose (FDG) positron emission tomography (PET). As a result, a number of …

Simple Summary The imaging of prostate cancer has evolved over the last few decades with
molecular imaging, especially Positron Emission Tomography (PET) replacing conventional …

Prostate cancer is a prevalent public health problem worldwide. While imaging has played a
major role in this disease, there still remain many challenges and opportunities. Positron …

Imaging evaluation of prostate cancer needs to be tailored for various radiopharmaceuticals
being remarkably heterogeneous disease. Positron emission tomography (PET) has played …

Clinical/methodical issue In the last few years nuclear medical diagnostics have
experienced a unprecedented renaissance in the diagnostics of prostate cancer, due to the …

Prostate cancer is most commonly imaged through a combination of magnetic resonance
imaging, x-ray computed tomography, and 99m Tc-methylene diphosphonate bone scan …

Prostate cancer is characterized by evolution from a clinically localized hormone-naïve state
in the prostate gland to an eventually castration-resistant metastatic state. Clinical imaging …